ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 944,66
-0,20%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Arcellx Inc (ACLX)

  7. Arcellx Inc (ACLX) Actualités

ACLX

Arcellx (ACLX)

Arcellx Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ACLX
DateHeureSourceTitreSymboleSociété
09/05/202422h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACLXArcellx Inc
09/05/202422h05Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma ProgramNASDAQ:ACLXArcellx Inc
09/05/202422h05Business WireArcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma ProgramNASDAQ:ACLXArcellx Inc
09/05/202422h00Business WireArcellx Provides First Quarter 2024 Financial ResultsNASDAQ:ACLXArcellx Inc
07/05/202422h00Business WireArcellx to Participate in Two Upcoming Investor ConferencesNASDAQ:ACLXArcellx Inc
04/04/202422h00Business WireArcellx to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ACLXArcellx Inc
20/03/202421h00Business WireArcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:ACLXArcellx Inc
08/03/202400h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACLXArcellx Inc
29/02/202422h00PR Newswire (US)Arcellx to Participate at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:ACLXArcellx Inc
28/02/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACLXArcellx Inc
28/02/202422h00PR Newswire (US)Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business HighlightsNASDAQ:ACLXArcellx Inc
14/02/202423h57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACLXArcellx Inc
13/02/202401h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACLXArcellx Inc
02/01/202422h22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACLXArcellx Inc
18/12/202322h16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ACLXArcellx Inc
08/12/202322h00PR Newswire (US)Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASHNASDAQ:ACLXArcellx Inc
15/11/202314h30Dow Jones NewsArcellx Shares Rise Premarket on Expanded Gilead CollaborationNASDAQ:ACLXArcellx Inc
15/11/202312h58Dow Jones NewsGilead Invests Further in Arcellx, Extends CollaborationNASDAQ:ACLXArcellx Inc
15/11/202312h00PR Newswire (US)ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIPNASDAQ:ACLXArcellx Inc
15/11/202312h00Business WireKite and Arcellx Announce Expansion in Strategic PartnershipNASDAQ:ACLXArcellx Inc
13/11/202322h00PR Newswire (US)Arcellx Provides Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:ACLXArcellx Inc
02/11/202314h00PR Newswire (US)Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and ExpositionNASDAQ:ACLXArcellx Inc
14/08/202322h00PR Newswire (US)Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial ResultsNASDAQ:ACLXArcellx Inc
21/07/202322h44Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACLXArcellx Inc
23/06/202320h32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACLXArcellx Inc
20/06/202312h57Dow Jones NewsArcellx Shares Drop After Patient Death Draws Clinical Hold from FDANASDAQ:ACLXArcellx Inc
20/06/202301h46PR Newswire (US)Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical ProgramNASDAQ:ACLXArcellx Inc
16/06/202322h58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACLXArcellx Inc
01/06/202300h14Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ACLXArcellx Inc
09/05/202322h09Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:ACLXArcellx Inc
 Showing the most relevant articles for your search:NASDAQ:ACLX

Dernières Valeurs Consultées

BSTP
CVXEUR
Convex Token
COIN
NTCETH
LSE
LONG
Longships
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés